Self-Assembling Drugs Have Antibody, Nanotube, Payload

By Anette BreindlScience Editor

Tuesday, October 1, 2013

“There’s been a lot of effort over the past decade to use nanomaterials as delivery vehicles,” David Scheinberg told BioWorld Today. But in practice, that effort has often hit snags, due to the way the body deals with those nanomaterials. Specifically, once nanoparticles are combined with their payload, they often assume the sort of shape that gets them targeted for disposal via the liver or spleen. And there, they often are cleared slowly.